Septic arthritis due to Neisseria gonorrhoea in Western Australia.
Western Australia
gonococcal
incidence
outcome
risk factors
septic arthritis
Journal
Internal medicine journal
ISSN: 1445-5994
Titre abrégé: Intern Med J
Pays: Australia
ID NLM: 101092952
Informations de publication
Date de publication:
06 2022
06 2022
Historique:
revised:
30
11
2020
received:
22
09
2020
accepted:
14
12
2020
pubmed:
22
12
2020
medline:
22
6
2022
entrez:
21
12
2020
Statut:
ppublish
Résumé
A high prevalence of gonococcal infections has been reported from remote parts of Western Australia, but the occurrence of disseminated infection leading to arthritis has not been studied. To investigate the frequency, risk factors and long-term outcome of gonococcal arthritis (GA) in Western Australia (WA). A population-based data linkage study of patients with a hospital-based diagnosis of GA in WA between 1990 and 2014. Demographics, standardised incidence rates per million and comorbidity accrued before (lookback 186 months, interquartile range (IQR) 86-267) and after the index hospital contact for GA (follow up 100 months, IQR 60-209) are presented as frequency (%), median (IQR) or rates /1000 months. In total, 98 patients were diagnosed with GA. The annual incidence of GA increased from 1.35 to 2.10 per million between 1990 and 2014, but the rate of GA complicating all gonococcal infections was stable around 0.25%. Female patients with GA (54%; n = 53/98) were younger (24 vs 38 years) and more frequently identified as indigenous (88% vs 49%) than male patients (46%; n = 45/98; P = 0.002). Female patients had higher rates of prior infections (15.5 vs 8.1 per 1000 months; P = 0.002) and diabetes mellitus (15.9% vs 2.5%; P = 0.03) and a longer hospital stay (10 vs 8 days; P = 0.02). GA recurrence rate during follow up was low (2%), but a broad range of comorbidities developed contributing to a 14% crude death rate. GA stably complicates 0.25% of gonococcal infections in WA with young indigenous females and middle-aged non-indigenous males most affected. Prior infectious disease and diabetes mellitus are potential risk factors for GA in females. GA recurs rarely, but its development reflects a high risk of morbidity and mortality over the following 10 years.
Sections du résumé
BACKGROUND
A high prevalence of gonococcal infections has been reported from remote parts of Western Australia, but the occurrence of disseminated infection leading to arthritis has not been studied.
AIMS
To investigate the frequency, risk factors and long-term outcome of gonococcal arthritis (GA) in Western Australia (WA).
METHODS
A population-based data linkage study of patients with a hospital-based diagnosis of GA in WA between 1990 and 2014. Demographics, standardised incidence rates per million and comorbidity accrued before (lookback 186 months, interquartile range (IQR) 86-267) and after the index hospital contact for GA (follow up 100 months, IQR 60-209) are presented as frequency (%), median (IQR) or rates /1000 months.
RESULTS
In total, 98 patients were diagnosed with GA. The annual incidence of GA increased from 1.35 to 2.10 per million between 1990 and 2014, but the rate of GA complicating all gonococcal infections was stable around 0.25%. Female patients with GA (54%; n = 53/98) were younger (24 vs 38 years) and more frequently identified as indigenous (88% vs 49%) than male patients (46%; n = 45/98; P = 0.002). Female patients had higher rates of prior infections (15.5 vs 8.1 per 1000 months; P = 0.002) and diabetes mellitus (15.9% vs 2.5%; P = 0.03) and a longer hospital stay (10 vs 8 days; P = 0.02). GA recurrence rate during follow up was low (2%), but a broad range of comorbidities developed contributing to a 14% crude death rate.
CONCLUSIONS
GA stably complicates 0.25% of gonococcal infections in WA with young indigenous females and middle-aged non-indigenous males most affected. Prior infectious disease and diabetes mellitus are potential risk factors for GA in females. GA recurs rarely, but its development reflects a high risk of morbidity and mortality over the following 10 years.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1029-1034Informations de copyright
© 2020 Royal Australasian College of Physicians.
Références
Ferrand J, El Samad Y, Brunschweiler B, Grados F, Dehamchia-Rehailia N, Séjourne A et al. Morbimortality in adult patients with septic arthritis: a three-year hospital-based study. BMC Infect Dis 2016; 16: 239.
Garcia-De La Torre I, Nava-Zavala A. Gonococcal and nongonococcal arthritis. Rheum Dis Clin North Am 2009; 35: 63-73.
Meijers KA, Dijkmans BA, Hermans J, van den Broek PJ, Cats A. Non-gonococcal infectious arthritis: a retrospective study. J Infect 1987; 14: 13-20.
Moegle C, Grillon A, Anheim M, Lipsker D, Velter C. Impulse control disorder-linked hypersexuality complicated by disseminated gonococcal infection in a patient with Parkinson's disease. Rev Neurol (Paris) 2020; 176: 292-3.
Belkacem A, Caumes E, Ouanich J, Jarlier V, Dellion S, Cazenave B et al. Changing patterns of disseminated gonococcal infection in France: cross-sectional data 2009-2011. Sex Transm Infect 2013; 89: 613-5.
Rice PA. Gonococcal arthritis (disseminated gonococcal infection). Infect Dis Clin North Am 2005; 19: 853-61.
Cucurull E, Espinoza LR. Gonococcal arthritis. Rheum Dis Clin North Am 1998; 24: 305-22.
Suzaki A, Hayashi K, Kosuge K, Soma M, Hayakawa S. Disseminated gonococcal infection in Japan: a case report and literature review. Intern Med 2011; 50: 2039-43.
Lahra MM, Enriquez RP, National Neisseria Network. Australian gonococcal surveillance programme annual report, 2015. Commun Dis Intell 2017; 41: E60-E7.
Birrell JM, Gunathilake M, Singleton S, Williams S, Krause V. Characteristics and impact of disseminated gonococcal infection in the ‘top end’ of Australia. Am J Trop Med Hyg 2019; 101: 753-60.
Tuttle CS, Van Dantzig T, Brady S, Ward J, Maguire G. The epidemiology of gonococcal arthritis in an indigenous Australian population. Sex Transm Infect 2015; 91: 497-501.
Al Suwayyid BA, Coombs GW, Speers DJ, Pearson J, Wise MJ, Kahler CM. Genomic epidemiology and population structure of Neisseria gonorrhoeae from remote highly endemic western Australian populations. BMC Genomics 2018; 19: 165.
Kelman CW, Bass AJ, Holman CD. Research use of linked health data - a best practice protocol. Aust N Z J Public Health 2002; 26: 251-5.
Holman CD, Bass AJ, Rouse IL, Hobbs MS. Population-based linkage of health records in Western Australia: development of a health services research linked database. Aust N Z J Public Health 1999; 23: 453-9.
Bleich AT, Sheffield JS, Wendel GD Jr, Sigman A, Cunningham FG. Disseminated gonococcal infection in women. Obstet Gynecol 2012; 119: 597-602.
Tektonidou MG, Wang Z, Dasgupta A, Ward MM. Burden of serious infections in adults with systemic lupus erythematosus: a national population-based study, 1996-2011. Arthritis Care Res (Hoboken) 2015; 67: 1078-85.
Martin DO, Austin H. Exact estimates for a rate ratio. Epidemiology 1996; 7: 29-33.
Bardin T. Gonococcal arthritis. Best Pract Res Clin Rheumatol 2003; 17: 201-8.
Smith EL, Hodgetts KE, Ralph AP, Anstey NM. Case report: severe disseminated gonococcal infection with polyarticular gout: two cases in older travelers. Am J Trop Med Hyg 2019; 100: 209-12.
Crew PE, Abara WE, McCulley L, Waldron PE, Kirkcaldy RD, Weston EJ et al. Disseminated gonococcal infections in patients receiving eculizumab: a case series. Clin Infect Dis 2019; 69: 596-600.